Latest News

TCTAP 2024

Moderate AS in HFrEF: Time to Treat is Now & Future Expectation from RCT

TAVR: Techniques and Issues

TCTAP 2024

How Can We Further Improve Reperfusion in AMI?: Revising or Novel Approach

ACS and Acute MI: Brand New Issues

TCTAP 2024

Revascularization for Left Main Disease: Updated Data, Global Guideline and Beyond

Left Main and Multi-Vessel Diseases: Updated Concept and Treatment

TCTAP 2024

Implications of the ISCHEMIA Trial on Patient Selection for CTO-PCI

CTO-PCI: To Treat, or Not To Treat

Download

Partner Events